# Filing Detail

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-24-098582
Filing Date
2024-08-19
Accepted
2024-08-19 16:33:42
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q/A | eldn-20240331.htm iXBRL | 10-Q/A | 1679762
2 | EX-31.3 | eldn-ex31_3.htm | EX-31.3 | 14364
3 | EX-31.4 | eldn-ex31_4.htm | EX-31.4 | 14482
4 | EX-32.3 | eldn-ex32_3.htm | EX-32.3 | 9011
5 | EX-32.4 | eldn-ex32_4.htm | EX-32.4 | 9073
| Complete submission text file | 0000950170-24-098582.txt |  | 7818366

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eldn-20240331.xsd | EX-101.SCH | 1118246
75 | EXTRACTED XBRL INSTANCE DOCUMENT | eldn-20240331_htm.xml | XML | 1374086

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36620 | Film No.: 241221098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)